Here are the DEF 14A proxy statements from Health Catalyst, Inc (HCAT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HCAT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCAT filings page.
Health Catalyst, Inc. is asking stockholders to act on four main items at its 2026 virtual annual meeting on July 16, 2026. Investors will vote to elect two Class I directors, Justin Spencer and Mathew Arens, to terms ending at the 2029 annual meeting, and to ratify Ernst & Young LLP as independent auditor for the year ending December 31, 2026.
Stockholders will also cast an advisory, non-binding “say‑on‑pay” vote on 2025 compensation for named executive officers. A key governance proposal would restate the certificate of incorporation to phase out the classified board so that, beginning with the 2029 annual meeting, all directors are elected annually. The record date is May 22, 2026, when 73,894,020 common shares were outstanding.